-
Pain is an important consideration for people with rheumatic and musculoskeletal diseases (RMDs)...
-
Many different agents are available to treat people with axSpA, but they do not always work...
-
An increased risk of adverse pregnancy and neonatal outcomes has been reported for pregnancies...
-
Attendees at UCD’s Charles Institute Seminar Series heard a presentation by Prof Xiaoli Wu on treatment...
-
Ibrutinib combined with bendamustine-rituximab improved PFS by 50 per cent for older patients with newly-diagnosed mantle...
-
The use of autologous stem cell transplant (ASCT) early in the course of treatment showed a...
-
The addition of nimotuzumab to gemcitabine increases OS in patients with KRAS wild-type advanced...
-
New research has provided important insight into what drives metastases in prostate cancer...
-
The use of a novel agent, sacituzumab govitecan, an antibody-drug conjugate, resulted...
-
Since the beginning of 2022, the Migraine Association of Ireland (MAI) has seen an increase in...
-
The 2022 Annual Conference of the Irish College of Ophthalmologists (ICO) took place from...
-
Finland has five times the number of neurologists that Ireland has, and only neurologists treat stroke...
ADVERTISEMENT
ADVERTISEMENT